Periodic Reporting for period 2 - IcoCell (Cell line development platform for SMEs to reduce the length and cost of biologic drug development)

Due to high development and production costs, biologic drugs are expensive for patients and reimbursement agencies ($45 per day vs. $2 per day in case of chemical drugs, on average), limiting the access to these therapies and burdening healthcare systems. To a great extent...